Allegheny Health Network | Strategic Alliance Partners

"I would basically look at these 3 things as the major things to be coming up," says Jitesh Dhingra, MD, FRCEM.

Dhingra discusses the utility of PSMA-PET imaging when treating patients with prostate cancer.

"This is a very exciting time for nuclear medicine and molecular medicine," says Jitesh Dhingra, MD, FRCEM.

“We don't have the sex therapists or psychologists who specialize in sexual dysfunction here... It's incredibly important, because if it doesn't start out as psychological, certainly, it becomes psychological, at least in some measure,” says Thomas M. Jaffe, MD.

“I definitely am more careful about who I offer Botox to in men,” says Gina M. Rooker, MD.

"There is a definite shortage, so not just increasing the diversity, but we have to increase the work force itself," says Sumit Saini, MD

“These are key, because right now our sepsis rates following ureteroscopy are, quite frankly, unacceptable,” says Jordan L. Allen, MD.

"It's certainly a bigger problem with advancing age in the geriatric population, and it can be a tremendous source of cost for patients who have these issues," says Gina M. Rooker, MD.

Study will evaluate whether blood-based testing can inform oncology providers about genetic variations within a patient’s cancer, which may influence choice of treatment based on cancer stage and type.